Effects of selective α1- and α2-adrenergic blockade on coronary flow reserve after coronary stenting

Circulation

Volumn 106, Issue 23, 2002, Pages 2901-2907

  Gregorini, Luisa ^b,c,f   Marco, Jean ^a   Farah, Bruno ^a   Bernies, Monique ^a   Palombo, Carlo ^d   Kozàkovà, Michaela ^d   Bossi, Irene M ^a   Cassagneau, Bernard ^a   Fajadet, Jean ^a   Di Mario, Carlo ^c   Albiero, Remo ^c   Cugno, Massimo ^b   Grossi, Adalberto ^b   Heusch, Gerd ^e  

^a CLINIQUE PASTEUR   (France)

^b UNIVERSITY OF MILAN   (Italy)

^c EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Adenosine; Blood flow; Microcirculation; Nervous system, sympathetic; Receptors, adrenergic, alpha

Indexed keywords

ADENOSINE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; URAPIDIL; YOHIMBINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT; PIPERAZINE DERIVATIVE;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY STENT; DRUG EFFECT; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; HYPEREMIA; HYPOTHESIS; MALE; PRIORITY JOURNAL; REVASCULARIZATION; UNSTABLE ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STENT; VASCULAR PATENCY;

ADENOSINE; ADRENERGIC ALPHA-ANTAGONISTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; STENTS; VASCULAR PATENCY; YOHIMBINE;

EID: 0037015907     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000040998.88272.A7     Document Type: Article

References (34)

1. Haude M, Caspari G, Baumgart D, et al. Comparison of myocardial perfusion reserve before and after balloon predilatation and after stent implantation in patients with postangioplasty restenosis. Circulation. 1996;94:286-297.
2. Nanto S, Kodama K, Hori M, et al. Temporal increase in resting coronary blood flow causes an impairment of coronary flow reserve after coronary angioplasty. Am Heart J. 1992;123:28-36.
3. van Liebergen RAM, Piek JJ, Kock KT, et al. Immediate and long-term effect of balloon angioplasty or stent implantation on the absolute and relative coronary flow velocity reserve. Circulation. 1998;98:2133-2140.
4. Gregorini L, Fajadet J, Robert G, et al. Coronary vasoconstriction following percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation. 1994;90:895-907.
5. Gregorini L, Marco J, Palombo C, et al. Post-ischemic left ventricular dysfunction is abolished by α-adrenergic blockers. J Am Coll Cardiol. 1998;31:992-1001.
6. Gregorini L, Marco J, Kozàkovà M. et al. α-Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Ctrculation. 1999;99:482-490.
7. 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol. 1984;6:961-968.
8. 2-adrenergic receptors in the coronary microcirculation. Circulation. 1991;84:2108-2122.
9. Baumgart D, Haude M, Goerge G, et al. Augmented α-adrenergic constriction of atherosclerotic human coronary arteries. Circulation. 1999;99:2090-2097.
10. Heusch G, Baumgart D, Camici PG, et al. α-Adrenergic coronary vaso-constriction and myocardial ischemia in man. Circulation. 2000;10:689-694.
11. Doucette JW, Corl PD, Paine HM, et al. Validation of Doppler guide wire for intravascular measurements of coronary artery flow velocity. Circulation. 1992;85:1899-1911.
12. Erbel R, Haude M, Hopp HW, et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty: Restenosis Stent Study Group. N Engl J Med. 1998;339:1672-1678.
13. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary circulation. Circulation. 1990;82:1595-1606.
14. Kern MJ, Deligonul U, Tatineni S, et al. Intravenous adenosine: Continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol. 1991;18:718-729.
15. 2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation. 1992;86:1116-1124.
16. 1 adrenergic blocking agent urapidil counteracts postrotational atherectomy "elastic recoil" where nitrates have failed. Am J Cardiol. 1997;79:1100-1103.
17. Limbruno U, Petronio AS, Amoroso G, et al. The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media. Circulation. 2000;101:491-497.
18. Bland MJ, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-309.
19. Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol. 1969;217:703-709.
20. Heusch G, Deussen A, Thämer V. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: Feed-back aggravation of myocardial ischemia. J Auton Nerv Syst. 1985;13:311-326.
21. Erbel R, Heusch G. Coronary microembolization. J Am Coll Cardiol. 2000;36:22-24.
22. Herrmann J, Haude M, Lerman A, et al. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation. 2001;103:2339-2345.
23. Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol. 1986;250:H509-H518.
24. Hori M, Tamai J, Kitakaze MT, et al. Adenosine-induced hyperemia attenuates myocardial ischemia in coronary microembolization in dogs. Am J Physiol. 1989;257:H244-H251.
25. Ryan TJ, Bauman WB, Kennedy JW, et al. Special report: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993;88:2987-3007.
26. Carlino M, De Gregorio J, Di Mario C, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty: Experience with a new temporary occlusion and aspiration system. Circulation. 1999;99:3221-3223.
27. 1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in humans. Am J Physiol. 1996;271:HI302-HI306.
28. Schwartz PJ, Stone HL. Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. Circ Res. 1977;41:51-58.
29. 2-Adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol. 1988;255:H250-H260.
30. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 1983;111:98-111.
31. Chester AH, O'Neil GS, Moncada S, et al. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 1990;336:897-900.
32. 1-Adrenoceptor activity regulates release of adenosine from ischemic myocardium in the dogs. Circ Res. 1987;60:631-639.
33. Nishigaki K, Faber JE, Ohyanagi M. Interaction between α-adrenoceptors and adenosine receptors on microvascular smooth muscle. Am J Physiol. 1991;29:HI655-HI666.
34. Smits P, Williams SB, Lipson DE, et al. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans, Circulation. 1995;92:2135-2141.